Mohamed Sherif's upcoming clinical trial of psychedelics to treat OCD is spotlighted in this Guardian article.

Alice Lin, Vanessa Rivera Núñez, Alisa Salazar, Lewis Núñez Severino and Zachary Uttke presented on findings that will advance research into Alzheimer's disease, developmental disorders, an epilepsy syndrome, obsessive compulsive disorder and post-traumatic stress disorder.